Lihua Elizabeth Budde

41PUBLICATIONS
203CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Jul 24, 2026
B-cell activating factor receptor expression in B-lymphoblastic leukaemia: Flow cytometric analysis and implications for targeted therapy.

|Jun 24, 2026
CAR T-cell therapy as a definitive consolidation for older adults with B-ALL in first complete remission.

|Apr 21, 2026
Mosunetuzumab plus polatuzumab vedotin for relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 study.

|Mar 20, 2026
Fixed-Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis.

Nancy L Bartlett, Laurie H Sehn, Sarit Assouline

|Feb 05, 2026
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter transformation.

Katharine Louise Lewis, Sarit E Assouline, Ross Ian Baker

|Jan 06, 2026
Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial.

Paolo Strati, Lori Leslie, Parveen Shiraz

Pageof 7

Frequent Collaborators

10 joint publications

Alex Herrera

7 joint publications

Nancy L Bartlett

6 joint publications

Matthew J Matasar

6 joint publications

John H Baird